Glenmark Pharmaceuticals Key Metrics
BSE: - | NSE: - | ISIN: - | Sector: -2,301.40 +19.15 (0.84%)Updated : 13 Jul 2026
Ratios
| Return on average equity - 5 year average | 2.91 |
| Net Income/employee - trailing 12 month | 0.00 |
| Revenue/employee - most recent fiscal year | 0.00 |
| Return on investment - most recent fiscal year | 11.53 |
| Return on average assets - most recent fiscal year | 7.58 |
| Receivables turnover - most recent fiscal year | 4.09 |
| Return on investment - trailing 12 month | 11.53 |
| Return on average assets - trailing 12 month | 7.58 |
| Inventory turnover - most recent fiscal year | 1.41 |
| Inventory turnover - trailing 12 month | 1.47 |
| Revenue/employee - trailing 12 month | 0.00 |
| Return on average assets - 5 year average | 1.75 |
| Net Income/employee - most recent fiscal year | 0.00 |
| Return on average equity - trailing 12 month | 14.07 |
| Receivables turnover - trailing 12 month | 4.09 |
| Asset turnover - most recent fiscal year | 0.94 |
| Asset turnover - trailing 12 month | 0.94 |
| Return on average equity - most recent fiscal year | 14.07 |
| Return on investment - 5 year average | 2.57 |
Glenmark Pharmaceuticals Quick Links
Glenmark Pharmaceuticals Dividend Glenmark Pharmaceuticals Bonus Glenmark Pharmaceuticals News Glenmark Pharmaceuticals AGM Glenmark Pharmaceuticals Rights Glenmark Pharmaceuticals Splits Glenmark Pharmaceuticals Board Meetings Glenmark Pharmaceuticals Shareholdings Glenmark Pharmaceuticals Profit Loss Glenmark Pharmaceuticals Balance Sheet Glenmark Pharmaceuticals Cashflow Glenmark Pharmaceuticals Q1 Results Glenmark Pharmaceuticals Q2 Results Glenmark Pharmaceuticals Q3 Results Glenmark Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,182.00+112.95(5.46%)
1,225.00+62.35(5.36%)
1,102.50+34.45(3.23%)
187.25-3.90 (-2.04%)
285.00-4.65 (-1.61%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.